146 related articles for article (PubMed ID: 339940)
1. Immunotherapy of acute myeloid leukaemia. Medical Research Council.
Br J Cancer; 1978 Jan; 37(1):1-14. PubMed ID: 339940
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
Zuhrie SR; Harris R; Freeman CB; MacIver JE; Geary CG; Delamore IW; Tooth JA
Br J Cancer; 1980 Mar; 41(3):372-7. PubMed ID: 6992827
[TBL] [Abstract][Full Text] [Related]
3. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
Powles R; Toy JL
Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy using BCG during remission induction and as the sole form of maintenance in acute myeloid leukaemia.
Summerfield GP; Gibbs TJ; Bellingham AJ
Br J Cancer; 1979 Nov; 40(5):736-42. PubMed ID: 389265
[TBL] [Abstract][Full Text] [Related]
5. The role of immunotherapy in acute myelogenous leukemia.
Foon KA; Smalley RV; Riggs CW; Gale RP
Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for acute myelogenous leukaemia.
Powles RL; Crowther D; Bateman CJ; Beard ME; McElwain TJ; Russell J; Lister TA; Whitehouse JM; Wrigley PF; Pike M; Alexander P; Fairley GH
Br J Cancer; 1973 Nov; 28(5):365-76. PubMed ID: 4271320
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy with chemotherapy in the maintenance of remission in acute myeloblastic leukaemia.
Whiteside MG; Cauchi MV; Paton CM
Med J Aust; 1976 Jul; 2(1):10-3. PubMed ID: 1068338
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.
Powles RL; Russell J; Lister TA; Oliver T; Whitehouse JM; Malpas J; Chapuis B; Crowther D; Alexander P
Br J Cancer; 1977 Mar; 35(3):265-72. PubMed ID: 322689
[TBL] [Abstract][Full Text] [Related]
9. Active immunotherapy for the treatment of acute myelogenous leukaemia: report of two controlled trials.
Whittaker JA; Bailey-Wood R; Hutchins S
Br J Haematol; 1980 Jul; 45(3):389-400. PubMed ID: 7000149
[TBL] [Abstract][Full Text] [Related]
10. Chemoimmunotherapy for maintenance in acute myeloblastic leukemia.
Whiteside MG; Cauchi MN; Paton C; Stone J
Cancer; 1976 Oct; 38(4):1581-6. PubMed ID: 1068741
[TBL] [Abstract][Full Text] [Related]
11. Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
Harris R; Zuhrie SR; Freeman CB; Taylor GM; MacIver JE; Geary CG; Delamore IW; Hull PJ; Tooth JA
Br J Cancer; 1978 Feb; 37(2):282-8. PubMed ID: 272913
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for acute myelogenous leukemia.
Powles RL; Lister TA; Crowther D; McElwain T; Alexander P; Fairley GH
Bibl Haematol; 1975; (40):737-49. PubMed ID: 1057948
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy and immunotherapy for acute myelogenous leukemia.
Lister TA; Whitehouse JM; Oliver RT; Bell R; Johnson SA; Wrigley PF; Ford JM; Cullen MH; Gregory W; Paxton AM; Malpas JS
Cancer; 1980 Nov; 46(10):2142-8. PubMed ID: 6932992
[TBL] [Abstract][Full Text] [Related]
14. Management of adult acute myelogenous leukaemia.
Crowther D; Powles RL; Bateman CJ; Beard ME; Gauci CL; Wrigley PF; Malpas JS; Fairley GH; Scott RB
Br Med J; 1973 Jan; 1(5846):131-7. PubMed ID: 4513355
[TBL] [Abstract][Full Text] [Related]
15. The nature of remission in acute myeloblastic leukaemia.
Powles RL; Selby PJ; Palu G; Morgenstern G; McElwain TJ; Clink HM; Alexander P
Lancet; 1979 Sep; 2(8144):674-6. PubMed ID: 90762
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of 100 acute myeloid leukemias (author's transl)].
Fière D; Martin C; Vu Van H; Coiffier B; Felman P; Bryon PA; Favre-Gilly J; Revol L
Sem Hop; 1979 Apr 8-15; 55(13-14):633-8. PubMed ID: 224478
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled study of chemoimmunotherapy of acute myelogenous leukemia (AML) in adults with Nocardia rubra cell-wall skeleton and irradiated allogeneic AML cells.
Ohno R; Nakamura H; Kodera Y; Ezaki K; Yokomaku S; Oguma S; Kubota Y; Shibata H; Ogawa N; Masaoka T
Cancer; 1986 Apr; 57(8):1483-8. PubMed ID: 3512070
[TBL] [Abstract][Full Text] [Related]
18. [Active immunotherapy of acute leukemia and leukemic lymphosarcoma. Results of 10 years. Study of 200 cases].
Mathé G; Amiel JL; Schwarzenberg L; Hayat M; Pouillart P; Schneider M; Cattan A; Jasmin C; Belpomme D; Schlumberger JR; De Vassal F; Musset M; Misset JL
Nouv Presse Med; 1975 May; 4(18):1337-42. PubMed ID: 1098015
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for acute myelogenous leukemia using irradiated and unirradiated leukemia cells.
Powles R
Cancer; 1974 Oct; 34(4 Suppl):suppl:1558-62. PubMed ID: 4608692
[No Abstract] [Full Text] [Related]
20. Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis.
Versluis J; Hazenberg CL; Passweg JR; van Putten WL; Maertens J; Biemond BJ; Theobald M; Graux C; Kuball J; Schouten HC; Pabst T; Löwenberg B; Ossenkoppele G; Vellenga E; Cornelissen JJ;
Lancet Haematol; 2015 Oct; 2(10):e427-36. PubMed ID: 26686044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
